SGMO - SANGAMO THERAPEUTICS, INC

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 0.723

Open

Bid

$ 0.72 x 600

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.29 - $ 1.48

Volume

3,483,966

Average Volume

Market Cap

150.54M

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-13-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	02-24-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	02-28-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-08-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-01-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	02-28-2017	12-31-2016	10-K
32	10-27-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	02-18-2016	12-31-2015	10-K
36	10-30-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	04-28-2015	03-31-2015	10-Q
39	02-25-2015	12-31-2014	10-K
40	10-28-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Sang...
08/22/2024 13:03:50

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

Sangamo Therapeutics Expects FY24 GAAP Bas...
08/06/2024 21:57:50

It expect non-GAAP total operating expenses, excluding estimated non-cash stock-based compensation expense of approximately $13...

Sangamo Therapeutics Q2 2024 GAAP EPS $(0....
08/06/2024 21:29:16

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate o...

Why Sangamo Therapeutics Stock Is Soaring
08/06/2024 17:39:48

Sangamo Therapeutics shares are trading higher Tuesday after the company announced it has entered into a license agreement with...

Sangamo Enters License Agreement With Gene...
08/06/2024 12:06:59

HC Wainwright & Co. Reiterates Buy on Sang...
07/31/2024 12:20:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

peering-into-sangamo-therapeuticss-recent-short-interest

Peering Into Sangamo Therapeutics's Recent...
07/25/2024 20:15:13

HC Wainwright & Co. Reiterates Buy on Sang...
07/24/2024 19:22:45

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

Crude Oil Gains 1%; AT&T Shares Rise After...
07/24/2024 18:37:16

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

dow-tumbles-300-points-tesla-shares-plunge-after-q2-results

Dow Tumbles 300 Points; Tesla Shares Plung...
07/24/2024 16:30:09

sangamo-stock-spikes-as-pfizer-partnership-meets-goal-in-late-stage-study

Sangamo Stock Spikes As Pfizer Partnership...
07/24/2024 16:10:52

Pfizer's Phase 3 AFFINE study of giroctocogene fitelparvovec gene therapy for hemophilia A meets key endpoints, showing a s...

Sangamo Therapeutics Shares Resume Trade
07/24/2024 13:43:14

Sangamo Therapeutics Shares Halted On Circ...
07/24/2024 13:37:53

Sangamo Therapeutics Announces Pfizer's Ph...
07/24/2024 12:28:17

Critical Insights From Sangamo Therapeutic...
05/15/2024 15:01:53

HC Wainwright & Co. Reiterates Buy on Sang...
05/15/2024 14:34:28

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

Sangamo Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 20:30:15

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

Sangamo Therapeutics Presents Modular Inte...
05/09/2024 12:45:44